133 related articles for article (PubMed ID: 24076229)
1. Polyvinyl acetate-based film coatings.
Kolter K; Dashevsky A; Irfan M; Bodmeier R
Int J Pharm; 2013 Dec; 457(2):470-9. PubMed ID: 24076229
[TBL] [Abstract][Full Text] [Related]
2. Compression of pellets coated with various aqueous polymer dispersions.
Dashevsky A; Kolter K; Bodmeier R
Int J Pharm; 2004 Jul; 279(1-2):19-26. PubMed ID: 15234790
[TBL] [Abstract][Full Text] [Related]
3. Influence of the components of Kollicoat SR film on mechanical properties of floating pellets from the point of view of tableting.
Lunio R; Sawicki W
Pharmazie; 2008 Oct; 63(10):731-5. PubMed ID: 18972835
[TBL] [Abstract][Full Text] [Related]
4. Effect of water-soluble polymers on the physical stability of aqueous polymeric dispersions and their implications on the drug release from coated pellets.
Dashevsky A; Ahmed AR; Mota J; Irfan M; Kolter K; Bodmeier RA
Drug Dev Ind Pharm; 2010 Feb; 36(2):152-60. PubMed ID: 20070182
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical and release properties of pellets coated with Kollicoat SR 30 D, a new aqueous polyvinyl acetate dispersion for extended release.
Dashevsky A; Wagner K; Kolter K; Bodmeier R
Int J Pharm; 2005 Feb; 290(1-2):15-23. PubMed ID: 15664126
[TBL] [Abstract][Full Text] [Related]
6. pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP.
Dashevsky A; Kolter K; Bodmeier R
Eur J Pharm Biopharm; 2004 Jul; 58(1):45-9. PubMed ID: 15207536
[TBL] [Abstract][Full Text] [Related]
7. Curing mechanism of flexible aqueous polymeric coatings.
Irfan M; Ahmed AR; Kolter K; Bodmeier R; Dashevskiy A
Eur J Pharm Biopharm; 2017 Jun; 115():186-196. PubMed ID: 28246029
[TBL] [Abstract][Full Text] [Related]
8. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
Ali R; Dashevsky A; Bodmeier R
Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the drug release patterns and long term stability of aqueous and organic coated pellets by using blends of enteric and gastrointestinal insoluble polymers.
Kranz H; Gutsche S
Int J Pharm; 2009 Oct; 380(1-2):112-9. PubMed ID: 19632313
[TBL] [Abstract][Full Text] [Related]
10. Water-insoluble polymers as binders for pellet drug layering: Effect on drug release and performance upon compression.
Zoubari G; Ali R; Dashevskiy A
Int J Pharm; 2019 Oct; 569():118520. PubMed ID: 31362093
[TBL] [Abstract][Full Text] [Related]
11. Drug release from Kollicoat SR 30D-coated nonpareil beads: evaluation of coating level, plasticizer type, and curing condition.
Shao ZJ; Moralesi L; Diaz S; Muhammadi NA
AAPS PharmSciTech; 2002; 3(2):E15. PubMed ID: 12916952
[TBL] [Abstract][Full Text] [Related]
12. Technology evaluation: Kollicoat IR.
Fouad EA; El-Badry M; Neau SH; Alanazi FK; Alsarra IA
Expert Opin Drug Deliv; 2011 May; 8(5):693-703. PubMed ID: 21417781
[TBL] [Abstract][Full Text] [Related]
13. Studies comparing Kollicoat MAE 30 D with commercial cellulose derivatives for enteric coating on caffeine cores.
Scheiffele S; Kolter K; Schepky G
Drug Dev Ind Pharm; 1998 Sep; 24(9):807-18. PubMed ID: 9876531
[TBL] [Abstract][Full Text] [Related]
14. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
Ghanam D; Kleinebudde P
Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel osmotically driven drug delivery system for weakly basic drugs.
Guthmann C; Lipp R; Wagner T; Kranz H
Eur J Pharm Biopharm; 2008 Jun; 69(2):667-74. PubMed ID: 18226884
[TBL] [Abstract][Full Text] [Related]
16. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D.
Sawicki W; Lunio R
Eur J Pharm Biopharm; 2005 May; 60(1):153-8. PubMed ID: 15848067
[TBL] [Abstract][Full Text] [Related]
17. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
Terebesi I; Bodmeier R
Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
[TBL] [Abstract][Full Text] [Related]
18. Variation of composition of an enteric formulation based on Kollicoat MAE 30 D.
Flösser A; Kolter K; Reich HB; Schepky G
Drug Dev Ind Pharm; 2000 Feb; 26(2):177-87. PubMed ID: 10697754
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies with Kollicoat MAE 30 D and Kollicoat MAE 30 DP in aqueous spray dispersions and enteric coatings on highly swellable caffeine cores.
Dangel C; Schepky G; Reich HB; Kolter K
Drug Dev Ind Pharm; 2000 Apr; 26(4):415-21. PubMed ID: 10769783
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the film formation of the dry coating process.
Kablitz CD; Urbanetz NA
Eur J Pharm Biopharm; 2007 Sep; 67(2):449-57. PubMed ID: 17451928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
